Home » Newsletters » BioWorld Science

BioWorld Science

July 26, 2002

View Archived Issues

Sangamo awarded grant to apply ZFP technology to treatment of sickle cell disease

Bayer Diagnostics to acquire Visible Genetics

G17DT receives orphan drug status in gastric cancer

Inhibition of amyloid fibrillation as a target for therapeutic intervention in AD4

Improving CNS drainage using COGNIShunt system may slow progression of AD

New formulation of Rapamune introduced in U.K.

GLI-5021: a novel therapeutic for acute and chronic myocardial ischemia

KRN-4884 mimics effects of hypoxic preconditioning in coronary preparations

PST-2744 tested in cardiomyopathic hamster model of heart failure

PPARgamma ligand protects heart from reperfusion injury

MCH1 receptor validated as promising target for Rx of obesity, depression and anxiety at Synaptic

Phase I/II results for VB2-011 encouraging

Aromatase inhibitor from Yamanouchi withdrawn from development

Access initiates OraDisc phase III trial, acquires rights to amlexanox

University of Kentucky researchers present morphine derivatives with analgesic activity

Oral formulation of YM-087 dropped from development

Novel bradykinin antagonists identified at Pfizer

Texas Biotechnology presents novel alpha4beta1 integrin antagonists

Daiichi discontinues development of nefiracetam in further territories

Novel antibacterial compounds isolated from Actinomadura sp. cultures

Integrin antagonists and their use in allergic rhinitis and other disorders

Merck describes basic research in the area of tyrosine kinase inhibitors

Thrombin receptor antagonists designed at Merck

FDA approves Zelnorm for IBS in women with constipation

Seattle Genetics provides second-quarter update

Regeneron initiates phase II testing of IL-1 Trap in rheumatoid arthritis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...